The Business of Biotech was back in San Francisco for JPM in January, and offers here a few observations, highlights, and ...

Recursion Pharmaceuticals (RXRX) added ~11% in the morning trading on Wednesday after J.P. Morgan upgraded the AI-driven biotech to Overweight from Neutral, citing a blockbuster sales potential for ...

Dr. James McCaffrey presents a complete end-to-end demonstration of decision tree regression from scratch using the C# language. The goal of decision tree regression is to predict a single numeric ...

Investors are split on whether the Federal Reserve will cut interest rates again at its next meeting in less than a month, amid uncertainty following the loss of economic data during the government ...

In the world of government contracting, your pipeline isn’t just a list of leads. It’s the heartbeat of your business. But managing that pipeline without a clear, consistent way to assess each ...

Management believes it can drastically cut down the time and cost to bring drugs to market. The company is involved with multiple clinical trials, but none of them are in late stages just yet. Its ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) stock is surging on Wednesday, without any news to justify the movement. Session volume stands at 69.3 million versus the average volume of 26.9 million, ...

The odds of the U.S. economy slipping into a recession have grown in recent months, according to global financial services company UBS. In an analysis cited by Fortune, the global financial services ...

We recently published 10 Resilient Stocks Defying Market Sentiment. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of Monday’s biggest gainers. Recursion Pharmaceuticals grew its share prices ...